These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

5601 related items for PubMed ID: 28826742

  • 1. A comprehensive review and update on Crohn's disease.
    Gajendran M, Loganathan P, Catinella AP, Hashash JG.
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [Abstract] [Full Text] [Related]

  • 2. Visceral adiposity and inflammatory bowel disease.
    Rowan CR, McManus J, Boland K, O'Toole A.
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [Abstract] [Full Text] [Related]

  • 3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F, Polymeros D, Panagiotou M, Theodoropoulos K, Rigopoulos D.
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [Abstract] [Full Text] [Related]

  • 4. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J.
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [Abstract] [Full Text] [Related]

  • 5. Allergic and Immunologic Perspectives of Inflammatory Bowel Disease.
    Clarke K, Chintanaboina J.
    Clin Rev Allergy Immunol; 2019 Oct; 57(2):179-193. PubMed ID: 29754190
    [Abstract] [Full Text] [Related]

  • 6. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.
    Cleynen I, González JR, Figueroa C, Franke A, McGovern D, Bortlík M, Crusius BJ, Vecchi M, Artieda M, Szczypiorska M, Bethge J, Arteta D, Ayala E, Danese S, van Hogezand RA, Panés J, Peña SA, Lukas M, Jewell DP, Schreiber S, Vermeire S, Sans M.
    Gut; 2013 Nov; 62(11):1556-65. PubMed ID: 23263249
    [Abstract] [Full Text] [Related]

  • 7. [Anti-TNF therapy in treatment of luminal Crohn's disease].
    Marko B, Prka L.
    Acta Med Croatica; 2013 Apr; 67(2):179-89. PubMed ID: 24471301
    [Abstract] [Full Text] [Related]

  • 8. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B.
    Dig Dis; 2009 Apr; 27(3):269-77. PubMed ID: 19786751
    [Abstract] [Full Text] [Related]

  • 9. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I, Rimola J, Rodríguez S, Paredes JM, Martínez-Pérez MJ, Blanc E, Arévalo JA, Aduna M, Andreu M, Radosevic A, Ramírez-Morros AM, Pinó S, Gallego M, Jauregui-Amezaga A, Ricart E, Panés J.
    Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
    [Abstract] [Full Text] [Related]

  • 10. Current therapy of inflammatory bowel disease in children.
    Rufo PA, Bousvaros A.
    Paediatr Drugs; 2006 Feb; 8(5):279-302. PubMed ID: 17037946
    [Abstract] [Full Text] [Related]

  • 11. AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.
    Hashash JG, Elkins J, Lewis JD, Binion DG.
    Gastroenterology; 2024 Mar; 166(3):521-532. PubMed ID: 38276922
    [Abstract] [Full Text] [Related]

  • 12. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, Colitis Foundation of America, Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD, Griffiths AM, Jevon GP, Higuchi LM, Hyams JS, Kirschner BS, Kugathasan S, Baldassano RN, Russo PA.
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [Abstract] [Full Text] [Related]

  • 13. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
    Simian D, Fluxá D, Flores L, Lubascher J, Ibáñez P, Figueroa C, Kronberg U, Acuña R, Moreno M, Quera R.
    World J Gastroenterol; 2016 Jun 14; 22(22):5267-75. PubMed ID: 27298570
    [Abstract] [Full Text] [Related]

  • 14. Optimising monitoring in the management of Crohn's disease: a physician's perspective.
    Papay P, Ignjatovic A, Karmiris K, Amarante H, Milheller P, Feagan B, D'Haens G, Marteau P, Reinisch W, Sturm A, Steinwurz F, Egan L, Panés J, Louis E, Colombel JF, Panaccione R.
    J Crohns Colitis; 2013 Sep 14; 7(8):653-69. PubMed ID: 23562672
    [Abstract] [Full Text] [Related]

  • 15. Maintenance of remission in Crohn's disease: current and emerging therapeutic options.
    Brookes MJ, Green JR.
    Drugs; 2004 Sep 14; 64(10):1069-89. PubMed ID: 15139787
    [Abstract] [Full Text] [Related]

  • 16. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun 14; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 17. A comprehensive review and update on ulcerative colitis.
    Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, Ziade N, Hashash JG.
    Dis Mon; 2019 Dec 14; 65(12):100851. PubMed ID: 30837080
    [Abstract] [Full Text] [Related]

  • 18. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F, Portela F.
    BioDrugs; 2010 Dec 14; 24 Suppl 1():3-14. PubMed ID: 21175228
    [Abstract] [Full Text] [Related]

  • 19. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M, Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens GR, van der Woude CJ, Danese S, Diamond RH, Oortwijn AF, Tang KL, Miller M, Cornillie F, Rutgeerts PJ, International Organization for the Study of Inflammatory Bowel Diseases.
    Gastroenterology; 2013 Nov 14; 145(5):978-986.e5. PubMed ID: 23954314
    [Abstract] [Full Text] [Related]

  • 20. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
    Walters TD, Kim MO, Denson LA, Griffiths AM, Dubinsky M, Markowitz J, Baldassano R, Crandall W, Rosh J, Pfefferkorn M, Otley A, Heyman MB, LeLeiko N, Baker S, Guthery SL, Evans J, Ziring D, Kellermayer R, Stephens M, Mack D, Oliva-Hemker M, Patel AS, Kirschner B, Moulton D, Cohen S, Kim S, Liu C, Essers J, Kugathasan S, Hyams JS, PRO-KIIDS Research Group.
    Gastroenterology; 2014 Feb 14; 146(2):383-91. PubMed ID: 24162032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 281.